Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer

NCT01461759 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Advanced or Recurrent Endometrial Cancer

Interventions

DRUG: Doctaxel
DRUG: Cisplatin

Sponsor

Asan Medical Center

Collaborators

[object Object]